QNTM
Quantum BioPharma Ltd.NASDAQHealthcare$3.58-10.05%ClosedMarket Cap: $14.7M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
2.01
P/S
0.00
EV/EBITDA
-0.60
DCF Value
$0.09
FCF Yield
-55.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-418.5%
ROA
-235.4%
ROIC
-220.0%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-2.4M | $-3.1M | $-0.79 | — |
| FY 2025 | $0.00 | -Infinity% | $-15.6M | $-26.6M | $-8.11 | — |
| Q3 2025 | $0.00 | -Infinity% | $-4.7M | $-5.3M | $-1.40 | — |
| Q2 2025 | $0.00 | NaN% | $-4.9M | $-9.3M | $-3.23 | — |
| Q1 2025 | $0.00 | NaN% | $-3.4M | $-8.6M | $-7.52 | — |
| Q4 2024 | $0.00 | NaN% | $-6.2M | $-5.4M | $-5.22 | — |
| FY 2024 | $0.00 | NaN% | $-16.1M | $-14.2M | $-12.49 | — |
| Q3 2024 | $0.00 | NaN% | $-4.2M | $-3.8M | $-4.17 | — |
| Q2 2024 | $0.00 | NaN% | $-3.5M | $-3.1M | $-4.85 | — |
| Q1 2024 | $0.00 | NaN% | $-2.3M | $-1.9M | $-3.12 | — |
| Q4 2023 | $0.00 | NaN% | $-1.8M | $-1.3M | $-2.18 | — |
| FY 2023 | $0.00 | NaN% | $-23.8M | $-17.9M | $-29.39 | — |